Global Respiratory Tract Infection Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431794
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie Inc.
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • F.Hoffman La Roche Ltd
  • GlaxoSmithkline plc
  • MORE
Respiratory Tract Infection Treatment Market Growth, Future Prospects, Competitive Analysis and Pipeline Analysis, 2017 - 2025, the global respiratory tract infection treatment market was valued at US$ 34,276.8 Mn in 2016, and is expected to reach US$ 59,957.3 Mn by 2025 expanding at a CAGR of 6.2% from 2017 to 2025.

Market Insights

Microbes gain entry to the respiratory tract by inhalation of droplets and invade the mucosa. Causative agents of lower respiratory infections are viral or bacterial. Symptoms include cough, fever, chest pain, tachypnea and sputum production. Patients with pneumonia may also exhibit non-respiratory symptoms such as confusion, headache, myalgia, abdominal pain, nausea, vomiting and diarrhea. In base year 2016, the upper respiratory tract infection are leading the disease segment due to factors such as constant climate change and air pollution, gross negligence when it comes to personal hygiene like sneezing, coughing (uncovered face) and touching inanimate objects with contaminated hands. Lower respiratory tract infection are anticipated to register faster growth in the disease segment throughout the forecast period 2017-2025, due to factors like rising number of air particulate matter, which causes respiratory tract irritation and infection and on the basis of transmission it might be hospital acquired, ventilator acquired, and community acquired. In 2016, NSAIDs holds the largest market in the drug class segment due to factors such as low cost and easy availability as OTC products, technological advancement in the drug formulation e.g. ketorolac nasal spray to overcome NSAIDs adverse events. The antibiotics will be the fastest growing market in the drug treatment segment throughout the forecast period 2017-2025, due to factors such as improved pharmacokinetics to specifically target the respiratory tract infection for e.g. Colistin inhalers. The respiratory tract infection treatment is technologically driven and includes major players such as Abbott Laboratories, AstraZeneca, Boehringer Ingelheim GmbH, Pfizer, Inc., Sanofi, Teva Pharmaceutical Industries Ltd. are few market leaders in respiratory tract infection treatment and compete to augment their foothold in the market.

Key Market Movements:
  • Higher public awareness and preference to maintain personal hygiene
  • Rising number of respiratory complications in children and geriatric population
  • Regulatory approval for drugs used in treatment for respiratory tract infection
  • Constantly changing climate and rise in air particulate matter due to industrial and automobile emission
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie Inc.
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • F.Hoffman La Roche Ltd
  • GlaxoSmithkline plc
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Respiratory Tract Infection Treatment Market Portraiture
2.2 Global Respiratory Tract Infection Treatment Market, by Disease, 2016 (US$ Mn)
2.3 Global Respiratory Tract Infection Treatment Market, by Drug Class, 2016 (US$ Mn)
2.4 Global Respiratory Tract Infection Treatment Market, by Geography, 2016 (Value %)

Chapter 3 Global Respiratory Tract Infection Treatment Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Constantly changing climate and rise in air particulate matter due to automobile and industrial emission
3.3 Market Restraints
3.3.1 Rising prevalence of antibiotic drug resistance
3.4 Market Opportunities
3.4.1 Rapid industrialization in the developing countries lading to increased air and water pollution will drive the respiratory tract infection treatment market in Asia Pacific
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Respiratory Tract Infection Treatment, by Key Players

Chapter 4 Global Respiratory Tract Infection Treatment Market, By Disease
4.1 Introduction
4.2 Upper respiratory tract infection
4.2.1 Common cold
4.2.2 Sinusitis
4.2.3 Epiglottitis
4.2.4 Laryngitis
4.3 Lower respiratory tract infection
4.3.1 Flu
4.3.2 Bronchitis
4.3.3 Pnuemonia
4.3.4 Chronic obstructive pulmonary disease (COPD)
4.3.5 Asthma
4.3.6 Respiratory syncytial virus

Chapter 5 Global Respiratory Tract Infection Treatment Market, By Drug Class
5.1 Market Analysis
5.2 Antibiotics
5.2.1 Antibacterial
5.2.1.1 Cephalosporin (ceftriaxone, cefotaxime)
5.2.1.2 Penicillin antibiotic (amoxicillin, ampicillin)
5.2.1.3 B lactactamase inhibitors (sulbactum,clavulanic acid)
5.2.2 Antiviral
5.2.2.1 Ribavarin
5.2.2.2 Palivizumab
5.2.2.3 Ganciclovir
5.2.2.4 Vidarabine
5.3 Non-steroidal anti-inflammatory drug (NSAIDS)
5.3.1 Paracetamol
5.3.2 Ibuprofen
5.3.3 Naproxen
5.3.4 Aspirin
5.4 Cough suppresant
5.4.1 Dextromethorphan
5.4.2 Pholcodine
5.4.3 Benzonatate
5.4.4 Diphenhydramine
5.5 Nasal decongestant
5.5.1 Phenylephrine
5.5.2 Oxymetazoline
5.5.3 Pseudoephedrine
5.6 Others

Chapter 6 Global Respiratory Tract Infection Treatment Market, By Geography
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia Pacific
6.5 Latin America
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of Latin America
6.6 Middle East and Africa
6.6.1 GCC
6.6.2 Rest of Middle East and Africa

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 AstraZeneca
7.3 Abbvie Inc.
7.4 Boehringer Ingelheim GmbH
7.5 Cipla Pharmaceutical Company
7.6 GlaxoSmithkline plc
7.7 Pfizer Inc.
7.8 Merck & Co.
7.9 Novartis AG
7.10 F.Hoffman La Roche Ltd
7.11 Sanofi
7.12 Teva Pharmaceutical Industries Ltd.
7.13 Theravence Biopharma
7.14 Vertex Pharmaceuticals Inc.
7.15 Others

List of Figures
Fig. 1 Global Respiratory Tract Infection Treatment Market: Research Methodology
Fig. 2 Global Respiratory Tract Infection Treatment Market, by Disease, 2016 (US$ Mn)
Fig. 3 Global Respiratory Tract Infection Treatment Market, by Drug Class, 2016 (US$ Mn)
Fig. 4 Global Respiratory Tract Infection Treatment Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition, by Geography, 2016
Fig. 6 Market Positioning of Key Respiratory Tract Infection Treatment Vendors, 2016
Fig. 7 Common Cold Infection Market, 2015 - 2025 (US$ Mn)
Fig. 8 Sinusitis Infection Market, 2015 - 2025 (US$ Mn)
Fig. 9 Epiglottitis Infection Market, 2015 - 2025 (US$ Mn)
Fig. 10 Laryngitis Infection Market, 2015 - 2025 (US$ Mn)
Fig. 11 Flu Infection Market, 2015 - 2025 (US$ Mn)
Fig. 12 Bronchitis Infection Market, 2015 - 2025 (US$ Mn)
Fig. 13 Pneumonia Infection Market, 2015 - 2025 (US$ Mn)
Fig. 14 Chronic Obstructive Pulmonary Disease Infection Market, 2015 - 2025 (US$ Mn)
Fig. 15 Asthma Infection Market, 2015 - 2025 (US$ Mn)
Fig. 16 Respiratory Syncytial Virus Infection Market, 2015 - 2025 (US$ Mn)
Fig. 17 Antibiotics Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 18 Non-steroidal Anti-inflammatory Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 19 Cough Suppresant Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 20 Nasal Decongestant Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 21 Others Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 22 U.S. Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 23 Canada Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 24 U.K. Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 25 Germnay Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 26 Rest of Europe Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 27 China Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 28 Japan Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 29 Rest of Asia Pacific Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 30 Brazil Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 31 Mexico Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 32 Rest of Latin America Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 33 GCC Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 34 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Respiratory Tract Infection Treatment Market, By Disease, 2015-2025 (US$ Mn)
Table 2 Global Upper Respiratory Tract Infection Treatment Market, 2015-2025 (US$ Mn)
Table 3 Global Lower Respiratory Tract Infection Treatment Market, 2015-2025 (US$ Mn)
Table 4 Global Respiratory Tract Infection Treatment Market, By Drug Class, 2015-2025 (US$ Mn)
Table 5 Global Respiratory Tract Infection Treatment Market, by Geography, 2015 - 2025 (US$ Mn)
Table 6 North America Respiratory Tract Infection Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Europe Respiratory Tract Infection Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 8 Asia Pacific Respiratory Tract Infection Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Latin America Respiratory Tract Infection Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Middle East and Africa Respiratory Tract Infection Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 11 Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 12 AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 13 Abbvie Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 14 Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 15 Cipla Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 16 GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 17 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 18 Merck & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 19 Novartis AG.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 20 F.Hoffman La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 21 Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 22 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 23 Theravence Biopharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 24 Vertex Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 25 Others: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • AstraZeneca
  • Abbvie Inc.
  • Boehringer Ingelheim GmbH
  • Cipla Pharmaceutical Company
  • GlaxoSmithkline plc
  • Pfizer Inc.
  • Merck & Co.
  • Novartis AG
  • F.Hoffman La Roche Ltd
  • Sanofi
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll